Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Collaboration symbols : TEVJF save search
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Sanofi and Teva Announce Exclusive Collaboration to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-10-04 (Crawled : 08:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: 1.46%
H: 0.21%
C: -5.65%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
disease treatment collaboration teva sanofi
Press Release: Sanofi and Teva announce exclusive collaboration to deliver inflammatory bowel disease treatment
Published: 2023-10-04 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
disease treatment collaboration teva sanofi
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published: 2023-09-04 (Crawled : 16:00) - prnewswire.com
MREO | $2.79 0.0% 790K
|
Health Technology
| Email alert
Add to watchlist
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
| Email alert
Add to watchlist
KIDS | News | $30.66 1.52% 1.5% 83K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
| Email alert
Add to watchlist
treatment research global collaboration growth
Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform
Published: 2022-11-14 (Crawled : 14:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: -2.74%
H: 4.56%
C: 1.3%
collaboration health teva unique respiratory platform
Global Peptide Therapeutics Market to Grow by USD 23.36 Bn, Collaboration for research and development to be the Key Trend - Technavio
Published: 2022-11-02 (Crawled : 09:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 3.27%
H: 2.19%
C: -3.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.21%
H: 0.0%
C: -0.14%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 0.8%
H: 1.45%
C: 0.81%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 0.63%
H: 0.61%
C: -1.2%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: -2.87%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.07%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.75%
H: 1.66%
C: -1.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.15%
H: 1.19%
C: -0.97%
research global collaboration therapeutics market
Regeneron Strengthens Commitment to Oncology through Purchase of Sanofi's Stake in the Regeneron and Sanofi Collaboration on Libtayo® (cemiplimab), a PD-1 Inhibitor Approved for Multiple Forms of Cancer
Published: 2022-06-02 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.55%
H: 0.0%
C: -0.12%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: -2.18%
H: 0.0%
C: -3.71%
libtayo collaboration approved cancer sanofi pd-1 inhibitor
Regeneron and Ultragenyx Collaborate to Commercialize Evkeeza® (evinacumab) Outside the United States
Published: 2022-01-07 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.86%
H: 0.0%
C: 0.0%
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
|
| O: -6.46%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
evkeeza commercialization collaboration
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
Published: 2021-10-26 (Crawled : 21:00) - biospace.com/
TEVA | $13.01 1.01% 0.0% 8.9M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
disease neurodegenerative collaboration oda drug license
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.